Haemonetics reports Q1 FY2023 earnings; no financial details in filing excerpt

HAEMONETICS CORP

2023-Q1 EPS reported $0.38 revenue$261,458,000

Press release dated August 10, 2022, covering quarter ended July 2, 2022, was furnished as exhibit.
No specific revenue, EPS, or segment data are available from the provided filing text.
Registrant is Haemonetics Corporation (HAE), a Massachusetts corporation trading on NYSE.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.